Anti-ACOT13 monoclonal antibody

Pre-made anti-ACOT13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ACOT13/ACOT13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2330-Ab-1/ GM-Tg-hg-IP2330-Ab-2Anti-Human ACOT13 monoclonal antibodyHuman
GM-Tg-rg-IP2330-Ab-1/ GM-Tg-rg-IP2330-Ab-2Anti-Rat ACOT13 monoclonal antibodyRat
GM-Tg-mg-IP2330-Ab-1/ GM-Tg-mg-IP2330-Ab-2Anti-Mouse ACOT13 monoclonal antibodyMouse
GM-Tg-cynog-IP2330-Ab-1/ GM-Tg-cynog-IP2330-Ab-2Anti-Cynomolgus/ Rhesus macaque ACOT13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2330-Ab-1/ GM-Tg-felg-IP2330-Ab-2Anti-Feline ACOT13 monoclonal antibodyFeline
GM-Tg-cang-IP2330-Ab-1/ GM-Tg-cang-IP2330-Ab-2Anti-Canine ACOT13 monoclonal antibodyCanine
GM-Tg-bovg-IP2330-Ab-1/ GM-Tg-bovg-IP2330-Ab-2Anti-Bovine ACOT13 monoclonal antibodyBovine
GM-Tg-equg-IP2330-Ab-1/ GM-Tg-equg-IP2330-Ab-2Anti-Equine ACOT13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2330-Ab-1/ GM-Tg-hg-IP2330-Ab-2; GM-Tg-rg-IP2330-Ab-1/ GM-Tg-rg-IP2330-Ab-2;
GM-Tg-mg-IP2330-Ab-1/ GM-Tg-mg-IP2330-Ab-2; GM-Tg-cynog-IP2330-Ab-1/ GM-Tg-cynog-IP2330-Ab-2;
GM-Tg-felg-IP2330-Ab-1/ GM-Tg-felg-IP2330-Ab-2; GM-Tg-cang-IP2330-Ab-1/ GM-Tg-cang-IP2330-Ab-2;
GM-Tg-bovg-IP2330-Ab-1/ GM-Tg-bovg-IP2330-Ab-2; GM-Tg-equg-IP2330-Ab-1/ GM-Tg-equg-IP2330-Ab-2
Products NameAnti-ACOT13 monoclonal antibody
Formatmab
Target NameACOT13
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ACOT13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2330-Ag-1Recombinant multi-species ACO13/ ACOT13/ HT012 protein


    Target information

    Target IDGM-IP2330
    Target NameACOT13
    Gene ID55856,66834,291135,100335133,610883,101087479,504870,100629805
    Gene Symbol and Synonyms0610006O17Rik,ACOT13,HT012,PNAS-27,THEM2
    Uniprot AccessionQ9NPJ3
    Uniprot Entry NameACO13_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112304
    Target ClassificationN/A

    The target: ACOT13, gene name: ACOT13, also named as HT012, PNAS-27, THEM2. This gene encodes a member of the thioesterase superfamily. In humans, the protein co-localizes with microtubules and is essential for sustained cell proliferation. The orthologous mouse protein forms a homotetramer and is associated with mitochondria. The mouse protein functions as a medium- and long-chain acyl-CoA thioesterase. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.